{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T14:34:49Z","timestamp":1784126089229,"version":"3.55.0"},"reference-count":35,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2025,5,31]]},"DOI":"10.1536\/ihj.24-668","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T22:08:00Z","timestamp":1747260480000},"page":"475-484","source":"Crossref","is-referenced-by-count":5,"title":["Remimazolam Inhibits Pyroptosis after Myocardial Ischemia-Reperfusion by Suppressing Nat10-Mediated Ac4C Acetylation of Nek7"],"prefix":"10.1536","volume":"66","author":[{"given":"Huafeng","family":"Feng","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, The Fifth Affiliated Hospital of Southern Medical University, Guangzhou"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Clinical Research Academy of Chinese Medicine, Guangzhou"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Bi","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, The Fifth Affiliated Hospital of Southern Medical University, Guangzhou"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihang","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Clinical Research Academy of Chinese Medicine, Guangzhou"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Lu L, Liu M, Sun R, <i>et al<\/i>. Myocardial Infarction: Symptoms and Treatments. Cell Biochem Biophys 2015; 72: 865-7.","DOI":"10.1007\/s12013-015-0553-4"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Bajaj A, Sethi A, Rathor P, <i>et al<\/i>. Acute Complications of Myocardial Infarction in the Current Era: Diagnosis and Management. J Investig Med 2015; 63: 844-55.","DOI":"10.1097\/JIM.0000000000000232"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Moraes-Silva IC, Rodrigues B, Coelho-Junior HJ, Feriani DJ, Irigoyen MC. Myocardial Infarction and Exercise Training: Evidence from Basic Science. Adv Exp Med Biol 2017; 999: 139-53.","DOI":"10.1007\/978-981-10-4307-9_9"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Murphy A, Goldberg S. Mechanical Complications of Myocardial Infarction. Am J Med 2022; 135: 1401-9.","DOI":"10.1016\/j.amjmed.2022.08.017"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Jacoby RM, Nesto RW. Acute myocardial infarction in the diabetic patient: Pathophysiology, clinical course and prognosis. J Am Coll Cardiol 1992; 20: 736-44.","DOI":"10.1016\/0735-1097(92)90033-J"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Li T, Tan Y, Ouyang S, <i>et al<\/i>. Resveratrol protects against myocardial ischemia-reperfusion injury via attenuating ferroptosis. Gene 2022; 808: 145968.","DOI":"10.1016\/j.gene.2021.145968"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Shi H, Gao Y, Dong Z, <i>et al<\/i>. GSDMD-Mediated Cardiomyocyte Pyroptosis Promotes Myocardial I\/R Injury. Circ Res 2021; 129: 383-96.","DOI":"10.1161\/CIRCRESAHA.120.318629"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Shen S, He F, Cheng C, <i>et al<\/i>. Uric acid aggravates myocardial ischemia-reperfusion injury via ROS\/NLRP3 pyroptosis pathway. Biomed Pharmacother 2021; 133: 110990.","DOI":"10.1016\/j.biopha.2020.110990"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Keam SJ. Remimazolam: First Approval. Drugs 2020; 80: 625-33.","DOI":"10.1007\/s40265-020-01299-8"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Lee A, Shirley M. Remimazolam: A Review in Procedural Sedation. Drugs 2021; 81: 1193-201.","DOI":"10.1007\/s40265-021-01544-8"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Shi M, Chen J, Liu T, <i>et al<\/i>. Protective Effects of Remimazolam on Cerebral Ischemia\/Reperfusion Injury in Rats by Inhibiting of NLRP3 Inflammasome-Dependent Pyroptosis. Drug Des Devel Ther 2022; 16: 413-23.","DOI":"10.2147\/DDDT.S344240"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Xu H, Chen Y, Xie P, <i>et al<\/i>. Remimazolam attenuates myocardial ischemia-reperfusion injury by inhibiting the NF-\u0138B pathway of macrophage inflammation. Eur J Pharmacol 2024; 965: 176276.","DOI":"10.1016\/j.ejphar.2023.176276"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Huang L, Li Q, Wen R, <i>et al<\/i>. Rho-kinase inhibitor prevents acute injury against transient focal cerebral ischemia by enhancing the expression and function of GABA receptors in rats. Eur J Pharmacol 2017; 797: 134-42.","DOI":"10.1016\/j.ejphar.2017.01.021"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Zhang Y, Lei Y, Dong Y, <i>et al<\/i>. Emerging roles of RNA ac4C modification and NAT10 in mammalian development and human diseases. Pharmacol Ther 2024; 253: 108576.","DOI":"10.1016\/j.pharmthera.2023.108576"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Luo J, Cao J, Chen C, <i>et al<\/i>. Emerging role of RNA acetylation modification ac4C in diseases: Current advances and future challenges. Biochem Pharmacol 2023; 213: 115628.","DOI":"10.1016\/j.bcp.2023.115628"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Wang X, Zhao Y, Zhang Q, <i>et al<\/i>. Acetylcytidine modification of Amotl1 by N-acetyltransferase 10 contributes to cardiac fibrotic expansion in mice after myocardial infarction. Acta Pharmacol Sin 2024; 45: 1425-37.","DOI":"10.1038\/s41401-024-01306-8"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Shi J, Yang C, Zhang J, <i>et al<\/i>. NAT10 Is Involved in Cardiac Remodeling Through ac4C-Mediated Transcriptomic Regulation. Circ Res 2023; 133: 989-1002.","DOI":"10.1161\/CIRCRESAHA.122.322244"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Li J, Yushanjiang F, Fang Z, <i>et al<\/i>. NAT10-mediated RNA ac4C acetylation contributes to the myocardial infarction-induced cardiac fibrosis. J Cell Mol Med 2024; 28: e70141.","DOI":"10.1111\/jcmm.70141"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Xie L, Zhong X, Cao W, <i>et al<\/i>. Mechanisms of NAT10 as ac4C writer in diseases. Mol Ther Nucleic Acids 2023; 32: 359-68.","DOI":"10.1016\/j.omtn.2023.03.023"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Wang K, Zhou L, Liu F, <i>et al<\/i>. PIWI-Interacting RNA HAAPIR Regulates Cardiomyocyte Death After Myocardial Infarction by Promoting NAT10-Mediated ac (4) C Acetylation of Tfec mRNA. Adv Sci (Weinh) 2022; 9: e2106058.","DOI":"10.1002\/advs.202106058"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Elbadawi A, Elgendy IY, Mahmoud K, <i>et al<\/i>. Temporal Trends and Outcomes of Mechanical Complications in Patients With Acute Myocardial Infarction. JACC Cardiovasc Interv 2019; 12: 1825-36.","DOI":"10.1016\/j.jcin.2019.04.039"},{"key":"22","first-page":"e9349","volume":"12","year":"2020","unstructured":"22. Khan M A, Hashim M J, Mustafa H, <i>et al<\/i>. Global Epidemiology of Ischemic Heart Disease: Results from the Global Burden of Disease Study. Cureus 2020; 12: e9349.","journal-title":"Cureus","ISSN":"https:\/\/id.crossref.org\/issn\/2168-8184","issn-type":"print"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Liu G, Xiong Y. Analysis of Stress Response and Analgesic Effect of Remazolam Combined with Etomidate in Painless Gastroenteroscopy. Contrast Media Mol Imaging 2022; 2022: 4863682.","DOI":"10.1155\/2022\/4863682"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kilpatrick GJ. Remimazolam: Non-Clinical and Clinical Profile of a New Sedative\/Anesthetic Agent. Front Pharmacol 2021; 12: 690875.","DOI":"10.3389\/fphar.2021.690875"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Ito S, Horikawa S, Suzuki T, <i>et al<\/i>. Human NAT10 is an ATP-dependent RNA acetyltransferase responsible for N4-acetylcytidine formation in 18 S ribosomal RNA (rRNA). J Biol Chem 2014; 289: 35724-30.","DOI":"10.1074\/jbc.C114.602698"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Zhang W, Gao J, Fan L, <i>et al<\/i>. ac4C acetylation regulates mRNA stability and translation efficiency in osteosarcoma. Heliyon 2023; 9: e17103.","DOI":"10.1016\/j.heliyon.2023.e17103"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Dorn L E, Tual-Chalot S, Stellos K, <i>et al<\/i>. RNA epigenetics and cardiovascular diseases. J Mol Cell Cardiol 2019; 129: 272-80.","DOI":"10.1016\/j.yjmcc.2019.03.010"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Stellos K. The rise of epitranscriptomic era: implications for cardiovascular disease. Cardiovasc Res 2017; 113: e2-3.","DOI":"10.1093\/cvr\/cvx030"},{"key":"29","doi-asserted-by":"publisher","unstructured":"29. Arango D, Sturgill D, Alhusaini N, <i>et al<\/i>. Acetylation of Cytidine in mRNA Promotes Translation Efficiency. Cell 2018; 175: 1872-86.","DOI":"10.1016\/j.cell.2018.10.030"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Hao Y, Li B, Yin F, <i>et al<\/i>. tRNA-derived small RNA (tsr007330) regulates myocardial fibrosis after myocardial infarction through NAT10-mediated ac4C acetylation of EGR3 mRNA. Biochim Biophys Acta Mol Basis Dis 2024; 1870: 167267.","DOI":"10.1016\/j.bbadis.2024.167267"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Qu Z, Pang X, Mei Z, <i>et al<\/i>. The positive feedback loop of the NAT10\/Mybbp1a\/p53 axis promotes cardiomyocyte ferroptosis to exacerbate cardiac I\/R injury. Redox Biol 2024; 72: 103145.","DOI":"10.1016\/j.redox.2024.103145"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. He Y, Zeng MY, Yang D, <i>et al<\/i>. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature 2016; 530: 354-7.","DOI":"10.1038\/nature16959"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Shi H, Wang Y, Li X, <i>et al<\/i>. NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component. Nat Immunol 2016; 17: 250-8.","DOI":"10.1038\/ni.3333"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Schmid-Burgk JL, Chauhan D, Schmidt T, <i>et al<\/i>. A Genome-wide CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Screen Identifies NEK7 as an Essential Component of NLRP3 Inflammasome Activation. J Biol Chem 2016; 291: 103-9.","DOI":"10.1074\/jbc.C115.700492"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Zhang H, Chen Z, Zhou J, <i>et al<\/i>. Author Correction: NAT10 regulates neutrophil pyroptosis in sepsis via acetylating ULK1 RNA and activating STING pathway. Commun Biol 2022; 5: 1091.","DOI":"10.1038\/s42003-022-04045-w"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/66\/3\/66_24-668\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T04:04:40Z","timestamp":1748664280000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/66\/3\/66_24-668\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,31]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.24-668","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,31]]},"article-number":"24-668"}}